Search bioRxiv⌕ Search

Biology subjects

Belz, L.

Publications and source records attributed to Belz, L..

2 recordsLinked to original sources

Dlx5/6 regulate perineuronal net-synapse coupling and stabilize adult cortical Parvalbumin neurons networks

The transcriptional mechanisms that maintain adult Parvalbumin (PV) interneuron function and cortical network stability remain poorly understood. We previously showed that the inactivation in GABAergic neurons of Dlx5/6, coding for transcription factors, disrupts social interaction and reduces PV interneuron density in the prefrontal cortex. Here, combining transcriptional and histological analyses with ex vivo electrophysiological and in vivo electroencephalographical (EEG) recordings, we show that Dlx5/6 regulate a molecular program controlling perineuronal net (PNN) homeostasis in the adult cortex. Dlx5/6 inactivation dysregulated the expression of multiple PNN-associated genes and induced region-specific remodelling of PNN mesh architecture in the prefrontal and somatosensory cortices. These structural changes were accompanied by alterations in excitatory and inhibitory synaptic organization and by a disrupted coupling between local PNN structure and synaptic properties. Ex vivo electrophysiological recordings revealed that fast-spiking interneurons displayed altered intrinsic properties and reduced excitatory synaptic drive in a region-specific manner, while EEG recordings during social interaction showed impaired recruitment of prefrontal gamma oscillations. Together, these findings identify Dlx5/6 as regulators of adult PV interneuron stability, linking extracellular matrix homeostasis to synaptic organization and cortical network dynamics. More broadly, it provides a new mechanistic framework connecting Dlx5/6 function to PV-related pathological phenotypes, including neuropsychiatric disorders. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=89 SRC="FIGDIR/small/740286v1_ufig1.gif" ALT="Figure 1"> View larger version (31K): org.highwire.dtl.DTLVardef@147c75dorg.highwire.dtl.DTLVardef@171e7d9org.highwire.dtl.DTLVardef@12c5c67org.highwire.dtl.DTLVardef@166790d_HPS_FORMAT_FIGEXP M_FIG C_FIG

neuroscience↗

Increased Osteoclast Activity Contributes to Bone Resorption and Osteopenia in a Rett Syndrome Mouse Model

Rett syndrome is a severe neurodevelopmental disorder caused predominantly by loss-of-function mutations in the X-linked gene MECP2. Besides a vast array of neurological and physiological impairments, patients also frequently develop severe osteopenia with increased fracture risk, however, the mechanisms underlying these skeletal defects are not completely understood. Previous work in Mecp2-null mouse models has suggested that osteopenia is mainly due to impaired osteoblast function and reduced bone formation. Here, we examined bone mass, microarchitecture, and remodeling parameters in a Mecp2-null mouse model during postnatal development, with a particular focus on osteoclast involvement. Micro-computed tomography and histomorphometric analyses showed reduced bone mineral density and trabecular bone volume, associated with increased trabecular separation and cortical thinning. These structural alterations were accompanied by increased osteoclast number per bone surface, elevated urinary deoxypyridinoline, and higher expression of osteoclast-associated genes, including Cathepsin K. Furthermore, gene expression analysis revealed an age-dependent shift in bone remodeling. At postnatal day 35, mutant mice showed reduced expression of Dlx5 and Dlx6, consistent with low bone turnover. By postnatal day 55, Rankl and Cathepsin K were markedly upregulated, suggesting an increase in osteoclast resorptive activity, while key osteoblast markers and the RANKL/OPG ratio did not change significantly. A potential cell-autonomous contribution of Mecp2 to osteoclast maturation is also suggested by the analysis of public transcriptomic datasets on human osteoclast differentiation. Together, our findings identify increased osteoclast activity as a significant contributor to Rett-associated osteopenia and suggest that skeletal pathology in Mecp2 deficiency progresses from an early low-turnover state to a later phase of increased osteoclast resorption. HIGHLIGHTSO_LIWhat are the main findings. O_LIMecp2-null mice display reduced bone mass and altered bone microarchitecture during postnatal development, associated not only with reduced osteoblast activity, but also with increased osteoclast number, elevated urinary deoxypyridinoline, and increased expression of osteoclast-associated genes. C_LIO_LIBone remodelling shows an age-dependent shift in Mecp2 deficiency, from an early low-turnover state at postnatal day 35 to increased osteoclast resorptive activity at postnatal day 55. C_LI C_LIO_LIWhat are the implications of the main findings? O_LIRett-associated osteopenia is not explained solely by impaired osteoblast function, but also involves a significant osteoclast contribution to skeletal deterioration. C_LIO_LIThese findings refine the pathophysiological model of bone involvement in Rett syndrome and support the idea that skeletal alterations evolve dynamically during disease progression. C_LI C_LI

genetics↗